Icon, the Dublin-based clinical trials group for pharmaceutical manufacturers globally, said that it overstated revenues by ...
ICON Public Limited (ICLR) posted its worst intraday stock performance in decades on Thursday after the company announced that it is withdrawing its previously issued 2025 financial guidance amid an ...
NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating ICON plc (NASDAQ: ICLR) following the company's disclosure on February 12, 2026, that an internal accounting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results